Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double-blind, Placebo-controlled Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)

NCT06182085 is registered in ClinicalTrials.gov with PRInnovation GmbH as lead sponsor.

NCT NCT06182085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06182085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double-blind, Placebo-controlled Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)
Lead sponsor
PRInnovation GmbH
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2024
Completion date
July 2, 2026
Enrollment
304 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, early onset, mild cognitive impairment due to alzheimer's disease